In this study, we examined the role of mTOR in the regulation of CD133+ CSCs differentiation, the conversion of CD133- conventional cancer cells to CD133+ CSCs, and the repopulation in vivo of mTOR-manipulated tumor cells. Here, PROM1 is linked to cancer.